- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07582848
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease
8 september 2026 uppdaterad av: Carelon Research
The primary objective of this study is to enhance the rates of direct breast feeding (DBF) among infants with congenital heart disease (CHD), and to gain insights into the implications of DBF on key metrics of child and parent well-being.
A multicenter parallel cluster platform design will be employed.
The intervention will be a multifaceted approach to enhance direct breastfeeding.
Participating sites will be randomized into either intervention (strategies to enhance direct breastfeeding) or conventional care.
Studieöversikt
Status
Rekrytering
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a domain of the Building Optimal Strategies to Enhance Parent and Infant Wellbeing in CHD (BOND) platform trail.
BOND is a randomized, multifactorial, adaptive platform trial that seeks to optimize parent wellbeing and infant development following prenatal or neonatal diagnosis of congenital heart disease (CHD).
The aim is to increase the proportion of infants with critical CHD who received direct breastfeeding at four months of age and to determine the impact of direct breastfeeding on maternal and infant health.
Infants with congenital heart disease have lower rates of breastfeeding than the healthy population.
Direct breastfeeding may be particularly beneficial in this population to reduce medical complications.
In addition, direct breastfeeding may benefit maternal child bonding and enhance maternal mental health.
Follow-up will continue through 12 months of infant age.
Studietyp
Interventionell
Inskrivning (Beräknad)
266
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Julie Miller, MPH
- Telefonnummer: 7812274645
- E-post: julie.miller2@carelon.com
Studera Kontakt Backup
- Namn: Stephanie Lynch, MPH
- Telefonnummer: 339-368-9294
- E-post: stephanie.lynch@carelon.com
Studieorter
-
-
Arizona
-
Phoenix, Arizona, Förenta staterna, 85016
- Har inte rekryterat ännu
- Phoenix Children's Hospital
-
Kontakt:
- Principal Investigator
-
-
California
-
Los Angeles, California, Förenta staterna, 90027
- Har inte rekryterat ännu
- Children's Hospital of Los Angeles
-
Kontakt:
- Principal Investigator
-
-
Colorado
-
Aurora, Colorado, Förenta staterna, 80045
- Har inte rekryterat ännu
- Children's Hospital Colorado
-
Kontakt:
- Principal Investigator
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30329
- Rekrytering
- Children's Healthcare of Atlanta
-
Kontakt:
- Principal Investigator
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60611
- Har inte rekryterat ännu
- Lurie Children's Hospital
-
Kontakt:
- Principal Investigator
-
-
Kentucky
-
Lexington, Kentucky, Förenta staterna, 40502
- Har inte rekryterat ännu
- Golisano Children's at UK
-
Kontakt:
- Principal Investigator
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02115
- Har inte rekryterat ännu
- Boston Children's Hospital
-
Kontakt:
- Principal Investigator
-
-
Michigan
-
Ann Arbor, Michigan, Förenta staterna, 48109
- Rekrytering
- University of Michigan Health System, Ann Arbor
-
Kontakt:
- Principal Investigator
-
-
Missouri
-
Kansas City, Missouri, Förenta staterna, 64108
- Har inte rekryterat ännu
- Children's Mercy Hospital
-
Kontakt:
- Principal Investigator
-
St Louis, Missouri, Förenta staterna, 63110
- Har inte rekryterat ännu
- Washington University School of Medicine
-
Kontakt:
- Principal Investigator
-
-
New York
-
New York, New York, Förenta staterna, 10029
- Har inte rekryterat ännu
- Icahn School of Medicine at Mount Sinai
-
Kontakt:
- Principal Investigator
-
New York, New York, Förenta staterna, 10032
- Har inte rekryterat ännu
- Children's Hospital of New York
-
Kontakt:
- Principal Investigator
-
-
Ohio
-
Cincinnati, Ohio, Förenta staterna, 45229
- Rekrytering
- Cincinnati Children's Hospital Medical Center
-
Kontakt:
- Principal Investigator
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Förenta staterna, 15213
- Har inte rekryterat ännu
- University of Pittsburgh Medical Center
-
Kontakt:
- Principal Investigator
-
-
South Carolina
-
Charleston, South Carolina, Förenta staterna, 29425
- Rekrytering
- Medical University of South Carolina
-
Kontakt:
- Principal Investigator
-
-
Tennessee
-
Memphis, Tennessee, Förenta staterna, 38103
- Rekrytering
- Le Bonheur Children's Hospital
-
Kontakt:
- Principal Investigator
-
-
Utah
-
Salt Lake City, Utah, Förenta staterna, 84113
- Har inte rekryterat ännu
- Primary Children's Medical Center
-
Kontakt:
- Principal Investigator
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Both mothers and infants are study participants.
Inclusion criteria:
- Pregnant individual carrying a fetus diagnosed with CHD or biological mother of an infant diagnosed with CHD in the neonatal period.
- Fetus or newborn with CHD anticipated to require cardiac surgery or transcatheter intervention in the first 30 days of life.
- Admission to the ICU (either CICU or NICU) at participating center in 1st week of life and for whom cardiac surgical or transcatheter intervention is anticipated in the first 30 days of life.
- Willing to comply with protocol and provide written informed consent
Exclusion Criteria:
- Mother, fetal, or infant medical condition determined by a treating clinician to be contraindicative to study participation.
- Mother with a severe, untreated psychiatric condition, substance use disorder, or other circumstances that, in the opinion of the investigator, would interfere with engagement with study tasks or safe participation in the trial.
- Mother with a moderate to severe intellectual disability or is otherwise unable to provide informed consent.
- Infant birthweight <3rd percentile for gestational age
- Infant gestational age < 36 weeks
- Infant with known genetic disorder likely to impact breastfeeding, such as trisomy 21 or cleft palate
- Medical condition or congenital anomaly that precludes safe direct breastfeeding for the infant as determined by investigator
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Breastfeeding clinical practice guideline (CPG)
The clinical practice guideline (CPG) intervention will be developed by the clinical centers randomized to this arm.
The intervention plan will likely include: 1) prenatal counseling; 2) viewing a video on breastfeeding CHD infants; 3) individual counseling by a registered lactation consultant (RLC), 4) weekly personal contact in-hospital by the RLC, 5) frequent contact post discharge by the RLC through the first year or until breastfeeding is discontinued, 6) provision of high-quality breast pumps, 7) incentive to continue with pumping breastmilk or direct breastfeeding.
|
The clinical practice guideline (CPG) intervention will be developed by the clinical centers randomized to this arm.
The intervention plan will likely include: 1) prenatal counseling; 2) viewing a video on breastfeeding CHD infants; 3) individual counseling by a registered lactation consultant (RLC), 4) weekly personal contact in-hospital by the RLC, 5) frequent contact post discharge by the RLC through the first year or until breastfeeding is discontinued, 6) provision of high-quality breast pumps, 7) incentive to continue with pumping breastmilk or direct breastfeeding.
|
|
Inget ingripande: Standard of Care
This arm will receive standard of care with respect to breastfeeding at the clinical centers randomized to this group.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
direct breastfeeding at 4 months
Tidsram: 4 months
|
any direct breastfeeding (yes/no)
|
4 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
direct breastfeeding at 4 months in subpopulation of African Americans
Tidsram: 4 months
|
any direct breastfeeding (yes/no) in subpopulation of African Americans
|
4 months
|
|
Difference in Parental Stress Scale™ (PSS) from baseline to 4 months
Tidsram: baseline to 4 months
|
The Parental Stress Scale™ (PSS) is a measure of parental stress.
The total score can range from 18 to 90, with higher scores indicating greater levels of parental stress and lower scores reflecting higher satisfaction with parenting.
|
baseline to 4 months
|
|
Difference in Mother-Infant Bonding Scale (MIBS) from baseline to 4 months
Tidsram: baseline to 4 months
|
The Mother-Infant Bonding Scale (MIBS) is a measure of mother-infant bonding.
The score ranges from 0-24, with higher scores indicating more significant bonding challenges
|
baseline to 4 months
|
|
Weight for age Z-score < -3 at 4 months
Tidsram: 4 months
|
WHO weight for age Z-score < -3
|
4 months
|
|
Freedom from necrotizing enterocolitis (NEC) through 4 months of age
Tidsram: 4 months
|
necrotizing enterocolitis
|
4 months
|
|
Freedom from infection through 4 months of age
Tidsram: 4 months
|
freedom from infection requiring hospital administration of antimicrobials for more than 48 hours
|
4 months
|
|
Freedom from other major medical complications through 4 months of age
Tidsram: baseline to 4 months
|
freedom from other major medical complications through 4 months of age
|
baseline to 4 months
|
|
Dysbiotic gut microbiome at 4 months of age
Tidsram: 4 months
|
Dysbiotic index measured from gut microbiome
|
4 months
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Studiestol: William Mahle, MD, Children's Healthcare of Atlanta
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
22 juli 2026
Primärt slutförande (Beräknad)
1 juni 2029
Avslutad studie (Beräknad)
1 augusti 2030
Studieregistreringsdatum
Först inskickad
29 april 2026
Först inskickad som uppfyllde QC-kriterierna
6 maj 2026
Första postat (Faktisk)
13 maj 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
10 september 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
8 september 2026
Senast verifierad
1 september 2026
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 20858 BOND Breastfeeding
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
JA
IPD-planbeskrivning
De-identified public use datasets with all study data will be created in accordance with NIH policy
Tidsram för IPD-delning
Data will be shared as soon as possible, but no later than the time of an associated publication or the end of the grant period, whichever comes first.
Data will be available for as long as it is deemed useful for the larger research community, as directed by the PHN NHLBI project officers.
Kriterier för IPD Sharing Access
Creation of (free) login on PHN public website
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .